NO20021763D0 - Modified peptides and peptide domimetics for use in immunotherapy - Google Patents

Modified peptides and peptide domimetics for use in immunotherapy

Info

Publication number
NO20021763D0
NO20021763D0 NO20021763A NO20021763A NO20021763D0 NO 20021763 D0 NO20021763 D0 NO 20021763D0 NO 20021763 A NO20021763 A NO 20021763A NO 20021763 A NO20021763 A NO 20021763A NO 20021763 D0 NO20021763 D0 NO 20021763D0
Authority
NO
Norway
Prior art keywords
domimetics
immunotherapy
peptide
modified peptides
peptides
Prior art date
Application number
NO20021763A
Other languages
Norwegian (no)
Other versions
NO20021763L (en
Inventor
Catherina Joanna Van Staveren
Cornelis Marius Maarris
Phillipus Johannes Marie Galen
Rnaldus Marcellus Alph Knegtel
Anna Maria Helena Boots
Andreas Martinus Ma Miltenburg
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NO20021763D0 publication Critical patent/NO20021763D0/en
Publication of NO20021763L publication Critical patent/NO20021763L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rehabilitation Therapy (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20021763A 1999-10-18 2002-04-15 Modified peptides and peptide domimetics for use in immunotherapy NO20021763L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99203427 1999-10-18
PCT/EP2000/010230 WO2001029081A1 (en) 1999-10-18 2000-10-12 Modified peptides and peptidomimetics for use in immunotherapy

Publications (2)

Publication Number Publication Date
NO20021763D0 true NO20021763D0 (en) 2002-04-15
NO20021763L NO20021763L (en) 2002-04-15

Family

ID=8240756

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021763A NO20021763L (en) 1999-10-18 2002-04-15 Modified peptides and peptide domimetics for use in immunotherapy

Country Status (23)

Country Link
EP (1) EP1226167A1 (en)
JP (1) JP2003512388A (en)
KR (1) KR20020047245A (en)
CN (1) CN1379786A (en)
AR (1) AR026068A1 (en)
AU (1) AU780238B2 (en)
BR (1) BR0014803A (en)
CA (1) CA2386398A1 (en)
CO (1) CO5271650A1 (en)
CZ (1) CZ20021356A3 (en)
HK (1) HK1046693A1 (en)
HU (1) HUP0203504A3 (en)
IL (1) IL148778A0 (en)
MX (1) MXPA02003520A (en)
NO (1) NO20021763L (en)
NZ (1) NZ518256A (en)
PE (1) PE20010692A1 (en)
PL (1) PL354590A1 (en)
RU (1) RU2002113107A (en)
SK (1) SK6842002A3 (en)
TR (1) TR200201036T2 (en)
WO (1) WO2001029081A1 (en)
ZA (1) ZA200202577B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002951212A0 (en) * 2002-09-04 2002-09-19 Monash University A method of modulating cellular activity and molecules for use therein
EP2016054A2 (en) * 2006-04-06 2009-01-21 Purdue Research Foundation Derivatization-enhanced analysis of amino acids and peptides
US20100278745A1 (en) * 2006-12-21 2010-11-04 Norbert Lange Compounds for fluorescence imaging
CN101971027A (en) 2008-01-23 2011-02-09 海莱乌医院 Ykl-40 as a general marker for non-specific disease
EP2340437A1 (en) 2008-09-15 2011-07-06 Herlev Hospital Ykl-40 as a marker for gastrointestinal cancers
AU2015342767B2 (en) 2014-11-07 2021-05-13 Kineta Chronic Pain, Llc Modifications and uses of conotoxin peptides
EP3466963A1 (en) * 2017-10-05 2019-04-10 Suigeneris Farmacosmetics, S.L. Anticancer peptides and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL115744A (en) * 1994-10-27 2000-07-16 Akzo Nobel Nv Peptides comprising a subsequence of human cartilage glycoprotein - 39
IL120561A0 (en) * 1996-04-24 1997-07-13 Akzo Nobel Nv Peptides suitable for use in immunosuppressive therapy
TR199802537T2 (en) * 1996-06-07 1999-03-22 Zeneca Limited Peptide tèrevleri.
IL122233A (en) * 1996-12-06 2001-04-30 Akzo Nobel Nv Method of preparing cell surface monolonal antibodies and pharmaceutical compositions and diagnostic reagents containing them

Also Published As

Publication number Publication date
TR200201036T2 (en) 2002-08-21
AR026068A1 (en) 2002-12-26
IL148778A0 (en) 2002-09-12
JP2003512388A (en) 2003-04-02
HK1046693A1 (en) 2003-01-24
HUP0203504A3 (en) 2005-03-29
SK6842002A3 (en) 2002-09-10
WO2001029081A1 (en) 2001-04-26
CZ20021356A3 (en) 2002-07-17
AU1139601A (en) 2001-04-30
AU780238B2 (en) 2005-03-10
NO20021763L (en) 2002-04-15
CA2386398A1 (en) 2001-04-26
BR0014803A (en) 2002-06-11
RU2002113107A (en) 2004-01-10
CO5271650A1 (en) 2003-04-30
PE20010692A1 (en) 2001-07-06
EP1226167A1 (en) 2002-07-31
KR20020047245A (en) 2002-06-21
ZA200202577B (en) 2003-09-23
PL354590A1 (en) 2004-01-26
CN1379786A (en) 2002-11-13
MXPA02003520A (en) 2002-08-20
NZ518256A (en) 2004-01-30
HUP0203504A2 (en) 2003-04-28

Similar Documents

Publication Publication Date Title
GB2338237B (en) In vitro peptide or protein expression library
EP1461605A4 (en) Protein and peptide nanoarrays
AU8079901A (en) Promyostatin peptides and methods of using same
HK1135330A1 (en) Short bioactive peptides and methods for their use
IL145850A0 (en) Adhesion modulatory peptides and methods for use
EP1362235A4 (en) Peptide or protein microassay method and apparatus
IL138946A0 (en) Method for the identification of peptides and proteins
NO20021763D0 (en) Modified peptides and peptide domimetics for use in immunotherapy
IL131707A0 (en) Acetylcholinesterase-derived peptides and uses thereof
GB9918155D0 (en) Proteins and peptides
NO995062D0 (en) <Beta> -anyloid peptide binding proteins and polynuldeotides encoded for the same
AU8542701A (en) Stress proteins and peptides and methods of use thereof
EP1210110A4 (en) Prion protein binding proteins and uses thereof
DE69816241D1 (en) ACTIVATED PEPTIDES AND CONJUGATES
GB0026134D0 (en) Peptides and their use
AU2003290886A8 (en) Modified alpha-msh peptides and derivatives thereof
NO20005547D0 (en) Myelin-based protein peptides and uses thereof
HUP0201660A2 (en) Novel polypeptide and dna thereof
ID27998A (en) NEW PEPTIDES FOR USE IN IMMUNOTHERAPY IN DISEASE OR ATOIMUN
EP1302477A4 (en) Peptide fructose and complex thereof with binding protein
IL145527A0 (en) Retro-inverso prosaposin-derived peptides and use thereof
NO20023364L (en) New peptide and method using the same
AU2003213933A8 (en) Purified polypeptides involved in protein synthesis and modification
EP1395276A4 (en) Structurally modified peptides and uses thereof
AU8557801A (en) Modified proteins, isolated novel peptides, and uses thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application